{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:55:40Z","timestamp":1791352540185,"version":"4.3.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Perpetual Guardian","award":["G-202202-00628"],"award-info":[{"award-number":["G-202202-00628"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Increases in childhood invasive pneumococcal disease (IPD) have been reported in several countries following the easing of COVID-19 pandemic mitigations. In Aotearoa New Zealand (AoNZ), a surge in IPD is occurring in young children concurrent with changes in pneumococcal vaccines and declining immunization coverage. We sought to examine epidemiologic and clinical features of IPD among children under 5 years in a large urban region of AoNZ in the 3 years post-COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Demographic, clinical and laboratory data were collated from children under 5 years with <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic> identified from normally sterile sites between January 1, 2021, and December 31, 2023, in T\u0101maki Makaurau Auckland, AoNZ.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We identified 93 episodes of IPD (annual incidence of 18\u201340 cases per 100,000 population per year). Serotype was identified in 68 episodes and 46 (68%) were serotype 19A. Incidence was higher in Pacific children compared with non-M\u0101ori, non-Pacific children (incidence rate ratio: 2.3; 95% confidence interval: 1.4\u20133.7). Bacteremia occurred in 65 (70%) episodes, empyema in 47 (51%), meningitis in 11 (12%) and hemolytic uremic syndrome in 7 (7.5%). All cases of hemolytic uremic syndrome and empyema were only among children with serotype 19A. Two children died, both had serotype 19A, and 13\/91 survivors (14%) experienced serious sequelae.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The use of the pneumococcal conjugate vaccine with lower valency and easing of COVID-19 containment measures each may have contributed to an increase in IPD in AoNZ. Serotype 19A is associated with empyema and causes severe disease in young children. Urgent efforts are required to improve PCV13 coverage in AoNZ.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004528","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T20:02:47Z","timestamp":1726084967000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Severe Invasive Pneumococcal Disease Caused by Serotype 19A in Children Under Five Years in T\u0101maki Makaurau Auckland, Aotearoa New Zealand"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9930-5573","authenticated-orcid":false,"given":"Cameron","family":"Burton","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Child and Youth Health, University of Auckland"},{"name":"Kidz First Children\u2019s Hospital, Te Whatu Ora Counties Manukau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9855-3919","authenticated-orcid":false,"given":"Rachel","family":"Webb","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Child and Youth Health, University of Auckland"},{"name":"Kidz First Children\u2019s Hospital, Te Whatu Ora Counties Manukau"},{"name":"Paediatric Infectious Diseases Service, Starship Children\u2019s Health, Te Whatu Ora Te Toka Tumai, Auckland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9091-496X","authenticated-orcid":false,"given":"Andrew","family":"Anglemyer","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, University of Otago, Dunedin"},{"name":"Health Intelligence Team, Institute of Environmental Science and Research, Wellington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Humphrey","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Service, Starship Children\u2019s Health, Te Whatu Ora Te Toka Tumai, Auckland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Tuato\u2019o","sequence":"additional","affiliation":[{"name":"Kidz First Children\u2019s Hospital, Te Whatu Ora Counties Manukau"},{"name":"School of Medicine, University of Auckland, Auckland, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2667-5458","authenticated-orcid":false,"given":"Emma","family":"Best","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Child and Youth Health, University of Auckland"},{"name":"Paediatric Infectious Diseases Service, Starship Children\u2019s Health, Te Whatu Ora Te Toka Tumai, Auckland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41479-022-00097-y","article-title":"The remarkable history of pneumococcal vaccination: an ongoing challenge.","volume":"14","author":"Musher","year":"2022","journal-title":"Pneumonia"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data.","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"e2218959","DOI":"10.1001\/jamanetworkopen.2022.18959","article-title":"Association of nonpharmaceutical interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France.","volume":"5","author":"Rybak","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R6-20250131","doi-asserted-by":"crossref","first-page":"e067519","DOI":"10.1136\/bmj-2021-067519","article-title":"Indirect effects of the COVID-19 pandemic on childhood infection in England: population based observational study.","volume":"376","author":"Kadambari","year":"2022","journal-title":"BMJ"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1097\/INF.0000000000003972","article-title":"Clinical and epidemiologic profile of invasive pneumococcal disease in Australian children following the relaxation of nonpharmaceutical interventions against SARS-COV-2.","volume":"42","author":"Williams","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3201\/eid2808.220304","article-title":"Increased incidence of invasive pneumococcal disease among children after COVID-19 pandemic, England.","volume":"28","author":"Bertran","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"R9-20250131","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciac100","article-title":"Reemergence of invasive pneumococcal disease in Germany during the spring and summer of 2021.","volume":"75","author":"Perniciaro","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R10-20250131","first-page":"101082","article-title":"The impact of pneumococcal serotype replacement on the effectiveness of a national immunization program: a population-based active surveillance cohort study in New Zealand.","volume":"46","author":"Anglemyer","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"R12-20250131","first-page":"100764","article-title":"Comparison of the epidemiology of invasive pneumococcal disease between Australia and New Zealand in 2017-2021: an observational study based on surveillance data.","volume":"36","author":"Hagedoorn","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"R16-20250131","first-page":"92","article-title":"New Zealand\u2019s immunisation policy fails again and entrenches ethnic disparities.","volume":"134","author":"Sinclair","year":"2021","journal-title":"N Z Med J"},{"key":"R17-20250131","doi-asserted-by":"crossref","first-page":"2301626","DOI":"10.1080\/21645515.2023.2301626","article-title":"Exploring the impact of the COVID-19 pandemic on perceptions of national scheduled childhood vaccines among M\u0101ori and Pacific caregivers, wh\u0101nau, and healthcare professionals in Aotearoa New Zealand.","volume":"20","author":"Charania","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"R20-20250131","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/cid\/ciab766","article-title":"Invasive pneumococcal disease: concerning trends in serotype 19A notifications in New Zealand.","volume":"74","author":"Anglemyer","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R21-20250131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1473-3099(20)30173-0","article-title":"Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study.","volume":"21","author":"Desmet","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R22-20250131","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00006454-199410000-00005","article-title":"Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand.","volume":"13","author":"Voss","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20250131","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1542\/peds.2007-2017","article-title":"Streptococcus pneumoniae-associated hemolytic uremic syndrome: classification and the emergence of serotype 19A.","volume":"125","author":"Copelovitch","year":"2010","journal-title":"Pediatrics"},{"key":"R30-20250131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1071\/HC17080","article-title":"Invasive pneumococcal disease and serotype emergence in the Auckland region during the vaccine era 2009\u201316.","volume":"11","author":"Eichler","year":"2019","journal-title":"J Prim Health Care"},{"key":"R34-20250131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1473-3099(14)71003-5","article-title":"Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand 2002\u201313: a multicentre retrospective cohort study.","volume":"15","author":"Schlapbach","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R35-20250131","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/archdischild-2017-313923","article-title":"Pneumococcal haemolytic uraemic syndrome in the postvaccine era.","volume":"103","author":"Lawrence","year":"2018","journal-title":"Arch Dis Child"},{"key":"R36-20250131","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1097\/INF.0000000000002368","article-title":"Pneumococcal-related hemolytic uremic syndrome in the United Kingdom: national surveillance, 2006\u20132016.","volume":"38","author":"Makwana","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R37-20250131","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/cid\/ciab510","article-title":"Pediatric Staphylococcus aureus bacteremia: clinical spectrum and predictors of poor outcome.","volume":"74","author":"Campbell","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R38-20250131","first-page":"33","article-title":"Invasive group A streptococcal disease in Hawke\u2019s Bay, New Zealand: epidemiology, manifestations and impact.","volume":"136","author":"Birrell","year":"2023","journal-title":"N Z Med J"},{"key":"R39-20250131","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3201\/eid2904.221397","article-title":"Pediatric invasive meningococcal disease, Auckland, New Zealand (Aotearoa), 2004\u20132020.","volume":"29","author":"Burton","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"R40-20250131","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamapediatrics.2019.3203","article-title":"Prevalence of immunodeficiency in children with invasive pneumococcal disease in the pneumococcal vaccine era: a systematic review.","volume":"173","author":"Butters","year":"2019","journal-title":"JAMA Pediatr"},{"key":"R41-20250131","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/INF.0000000000004004","article-title":"Inborn errors of immunity in children with invasive pneumococcal disease: a multicentre prospective study.","volume":"42","author":"Phuong","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R42-20250131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jinf.2008.10.011","article-title":"Association of respiratory virus activity and environmental factors with the incidence of invasive pneumococcal disease.","volume":"58","author":"Murdoch","year":"2009","journal-title":"J Infect"},{"key":"R43-20250131","doi-asserted-by":"crossref","first-page":"e13247","DOI":"10.1111\/irv.13247","article-title":"Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand.","volume":"18","author":"Huang","year":"2024","journal-title":"Influenza Other Respi Viruses"},{"key":"R44-20250131","first-page":"7","article-title":"What can we learn from our 2021 respiratory syncytial virus experience?","volume":"134","author":"Grant","year":"2021","journal-title":"N Z Med J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:03:59Z","timestamp":1738328639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004528","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]}}}